Hydroxyzine Syrup Suppliers & Bulk Manufacturers
Available Forms: Syrup
Available Strengths: 10 mg/5 mL, 25 mg/5 mL
Reference Brands: US: Vistaril®, , Atarax®; EU: Atarax®, Hydroxyzine Mylan®, Ucerax®
Category:
Antipsychotropic Drugs
Hydroxyzine syrup works by blocking H1 histamine receptors, reducing allergy symptoms like itching and hives. It also has anxiolytic and sedative effects through CNS depression, making it useful in managing anxiety, tension, and sleep disturbances in children and adults. The syrup form allows for flexible paediatric dosing.
Hydroxyzine Syrup is available in Syrup
and strengths such as 10 mg/5 mL, 25 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Hydroxyzine Syrup is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Hydroxyzine Syrup can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Hydroxyzine Syrup is FDA-approved in the USA for symptomatic relief of anxiety, tension, pruritus, and as a sedative pre- and post-operatively. It is often used in pediatric patients due to its liquid form, requiring child-specific dosing guidelines and safety labelling. In the European Union, hydroxyzine syrup is authorized in select member states under national procedures, with a strong emphasis on QT interval monitoring and age restrictions, especially in children. EU regulators require manufacturers to maintain pharmacovigilance systems and submit periodic safety reports. Explore other formulations and B2B suppliers at Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing